Dr. Lawrence P. Goldstick, MD

Dr. Goldstick practices at Surgery Center of Dayton, LLC in Dayton, Ohio.

Dr. Goldstick's NPI, 1508969445, was assigned on September 6, 2006. Dr. Goldstick graduated from College of Human Medicine - Grand Rapids in 1979. Dr. Goldstick holds Ohio license 35051165.

Dr. Goldstick's primary practice is Surgery Center of Dayton, LLC, at 1 Elizabeth Pl, Dayton, OH 45417 in Montgomery County. The practice phone is (937) 609-6232.

Dr. Goldstick's primary practice is Surgery Center of Dayton, LLC in Dayton, Ohio. Dr. Goldstick is also affiliated with Miami Valley Hospital. The medical group on file is University of Cincinnati Physicians. Dmand AI also links Dr. Goldstick to 4 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Goldstick practices, 7 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Goldstick's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Goldstick is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Goldstick is licensed in Ohio.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, cerebrovascular disease, epilepsy, essential tremor, fibromyalgia and chronic pain, lower back pain and migraine and chronic headache among the conditions Dr. Goldstick treats.

CMS data shows 403 Medicare services from Dr. Goldstick across 8 procedure codes in 2024, for 198 Medicare patients. Medicare paid $40,793 for them. Every service was in an office.

CMS counts 198 Medicare patients who saw Dr. Goldstick in 2024. The largest group is 65 to 74, with 80 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 13% are also on Medicaid. Their average risk score is 1.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Goldstick's median patient age at 60, with 64% women.

In 2024, Dr. Goldstick wrote 2,318 Medicare Part D claims for 316 patients. 86% of them were for generic drugs. CMS names the drug for 2,028 of them, across 49 drugs with 11 or more claims each, at $1,706,963 in total drug cost. In 2023, CMS named 2,629 claims across 54 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Goldstick for performance year 2024, reported as part of a group. Dr. Goldstick accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Goldstick as offering telehealth.

Dmand AI links 7 papers to Dr. Goldstick, published from 2014 to 2025. The most frequent topics are Multiple Sclerosis, Antibodies, Monoclonal, Humanized and Immunologic Factors. Dr. Goldstick has published most often in Neurology. Dr. Goldstick's most frequent co-authors are Scott Douglas Newsome, DO, Derrick Scott Robertson, MD and Elaine R. Wyllie, MD.

Dmand AI links Dr. Goldstick to 4 clinical trials. 1 is still active or recruiting. Conditions studied include Cognitive Dysfunction, Alzheimer Disease and Memory Disorders. Eli Lilly and Company sponsors the most, 4. Open Payments lists research payments to Dr. Goldstick that name 4 trials.

CMS Open Payments shows 2,899 general payments to Dr. Goldstick from 63 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 65% of the total. EMD Serono, Inc. paid the most, $229,487. It also lists 49 research payments totaling $117,621 from 2016 to 2025, naming 4 clinical trials.

Dmand AI lists 1 award for Dr. Goldstick, most recently CMS Stage 1 2012 in 2011.

Dr. Goldstick graduated from College of Human Medicine - Grand Rapids in 1979. Dr. Goldstick is a member of AAN.

Dr. Goldstick is in network with 20 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.